Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.08
-0.04 (-0.78%)
At close: Nov 14, 2024, 4:00 PM
4.842
-0.240 (-4.68%)
After-hours: Nov 14, 2024, 4:46 PM EST
Journey Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 22.46 | 27.44 | 32 | 49.08 | 8.25 | 4.8 |
Cash & Short-Term Investments | 22.46 | 27.44 | 32 | 49.08 | 8.25 | 4.8 |
Cash Growth | -9.24% | -14.26% | -34.80% | 495.21% | 71.76% | - |
Receivables | 10.67 | 15.22 | 28.21 | 23.11 | 23.93 | 18.96 |
Inventory | 11.79 | 10.21 | 14.16 | 9.86 | 1.4 | 0.86 |
Prepaid Expenses | 1.24 | 3.59 | 3.31 | 2.44 | 1.66 | 0.66 |
Total Current Assets | 46.16 | 56.46 | 77.68 | 84.49 | 35.24 | 25.27 |
Property, Plant & Equipment | 0.03 | 0.1 | 0.19 | 0.09 | 0.18 | 0.09 |
Other Intangible Assets | 17.84 | 20.29 | 27.2 | 12.55 | 15.03 | 7.38 |
Long-Term Deferred Tax Assets | - | - | - | - | 1.45 | 1.12 |
Other Long-Term Assets | 0.01 | 0.01 | 0.1 | 0.15 | 0.01 | 0.01 |
Total Assets | 64.04 | 76.85 | 105.16 | 97.28 | 51.91 | 33.86 |
Accounts Payable | 15.34 | 18.15 | 36.57 | 22.81 | 1.86 | 2.01 |
Accrued Expenses | 16.34 | 16.49 | 16.27 | 20.09 | 19.02 | 14.29 |
Short-Term Debt | - | - | 2.95 | 0.81 | - | - |
Current Portion of Long-Term Debt | 1.25 | 3 | 2.24 | 4.51 | 4.52 | - |
Current Portion of Leases | 0.03 | 0.1 | 0.08 | 0.1 | 0.09 | 0.08 |
Current Income Taxes Payable | - | 0.05 | 0.04 | 0.01 | - | - |
Other Current Liabilities | 0.37 | 4.08 | 8.68 | 3.28 | 2.58 | 4.52 |
Total Current Liabilities | 33.33 | 41.87 | 66.83 | 51.61 | 28.06 | 20.9 |
Long-Term Debt | 19.79 | 14.62 | 21.24 | 3.63 | 13.36 | 10.21 |
Long-Term Leases | - | 0.01 | 0.11 | - | 0.1 | - |
Other Long-Term Liabilities | - | - | - | - | 0.1 | - |
Total Liabilities | 53.12 | 56.5 | 88.18 | 55.24 | 41.61 | 31.11 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 99.47 | 92.7 | 85.48 | 80.92 | 5.17 | 2.91 |
Retained Earnings | -88.55 | -72.36 | -68.5 | -38.87 | 5.12 | -0.16 |
Shareholders' Equity | 10.93 | 20.35 | 16.98 | 42.04 | 10.29 | 2.75 |
Total Liabilities & Equity | 64.04 | 76.85 | 105.16 | 97.28 | 51.91 | 33.86 |
Total Debt | 21.07 | 17.73 | 26.62 | 9.05 | 18.06 | 10.29 |
Net Cash (Debt) | 1.39 | 9.71 | 5.38 | 40.03 | -9.82 | -5.49 |
Net Cash Growth | -93.56% | 80.40% | -86.56% | - | - | - |
Net Cash Per Share | 0.07 | 0.53 | 0.31 | 3.93 | -0.91 | -0.55 |
Filing Date Shares Outstanding | 20.89 | 19.93 | 17.83 | 17.32 | 9.15 | 9.13 |
Total Common Shares Outstanding | 20.73 | 19.32 | 17.77 | 17.32 | 9.15 | 9.13 |
Working Capital | 12.83 | 14.59 | 10.85 | 32.88 | 7.18 | 4.37 |
Book Value Per Share | 0.53 | 1.05 | 0.96 | 2.43 | 1.12 | 0.30 |
Tangible Book Value | -6.92 | 0.06 | -10.22 | 29.49 | -4.74 | -4.63 |
Tangible Book Value Per Share | -0.33 | 0.00 | -0.57 | 1.70 | -0.52 | -0.51 |
Leasehold Improvements | - | - | - | - | - | 0.01 |
Source: S&P Capital IQ. Standard template. Financial Sources.